Abstract

The aim of this study was to develop an assay to determine the level of fat tissue infiltration in muscle biopsies obtained from healthy humans. For this purpose, a muscle biopsy and subcutaneous adipose tissue were obtained from the musculus vastus lateralis in 14 healthy men (age = 33.1 ± 2 yr, height = 175.9 ± 1.7 cm, body mass = 81.2 ± 3.8 kg, body fat = 22.5 ± 1.9%). Protein extracts were prepared from the muscle biopsies and subcutaneous adipose tissue. Then, 50 μg of skeletal muscle protein extracts were run together with subcutaneous adipose tissue protein extract samples containing 1, 2, 3, 4, 5 μg of protein in the same gel. The Western blots were performed using a polyclonal rabbit anti-perilipin A antibody and normalized by alpha-tubulin optical density. From the band optical densities obtained for perilipin a standard curve was calculated by linear regression (all curves had a r2 value 0.98). The corresponding equation was used to calculate the amount of protein from fat origin present in each muscle biopsy. The muscle samples contained 1.18±0.13 micrograms of protein coming from adipose tissue in each 50 μg of protein muscle extract. This perilipin A band density corresponded to a level of adipose tissue protein contamination of 2.4±0.2% in the protein extract from the muscle biopsies. Thus, perilipin A content, a protein exclusive of adipocytes, can be used to determine the degree of adipose tissue infiltration in human skeletal muscle biopsies.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.